#18 The IDMP standards explained – Malin Fladvad & Olle Lagerlund

#18 The IDMP standards explained – Malin Flad...

Up next

#46 Protecting the health ecosystem – Valentina Giunchi & Joe Mitchell

Send a message to the show!Pharmacovigilance has traditionally focused on the patient at the receiving end of a medicine. But what happens to medicines once they leave the body? In this episode, Valentina Giunchi and Joe Mitchell unpack the emerging field of ecopharmacovigilance ...  Show more

#45 How to perform better disproportionality analyses – Michele Fusaroli & Eugene van Puijenbroek

Send a message to the show!For all its ease and speed, disproportionality analysis can be distorted by many biases, making it easy to misuse and misinterpret. Michele Fusaroli from Uppsala Monitoring Centre and Eugene van Puijenbroek from the Netherlands pharmacovigilance centre ...  Show more

Recommended Episodes

Safe Handling of Hazardous Drugs: ASCO Standards
ASCO Guidelines

An interview with Dr. Paul Celano from the Greater Baltimore Medical Center on the recently published ASCO Standards on safe handling of hazardous drugs. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not int ...  Show more

Prescribing safety
RCGP eLearning Podcast

In this podcast, Dr Emma Nash talks to Professor Tony Avery, GP, Professor of Primary Health Care at the University of Nottingham, and National Clinical Director for Prescribing. Key points from the two prescribing safety modules are touched on, in the context of the Medicines Sa ...  Show more

Reducing Inequality With Precision Public Health
One-on-One with Eric Topol

Eric Topol talks with Sue Desmond-Hellmann about her multidimensional career and how to scale precision medicine for global public health. 

Using Real-World Studies to Compare DMTs in MS
The ECTRIMS Podcast

Tomas Kalincik, Head of the Clinical Outcomes Research Unit at the University of Melbourne, and Maria Pia Sormani, Professor of Biostatistics at the University of Genoa, discuss the use of real-world data to compare disease-modifying treatments (DMTs) in multiple sclerosis, inclu ...  Show more